WRAIR Scientist Honored for Antimalarial Drug Development

Dr. Richard Sciotti Recognized as Laboratory Scientist of the Quarter

Dr. Richard Sciotti from the U.S. Army Medical Research and Materiel Command (MRMC) is honored as the 2018 first quarter winner of the Department of Defense (DoD) Laboratory Scientist of the Quarter Award. Dr. Sciotti is a Senior Scientist and Chief of Medicinal Chemistry for Experimental Therapeutics (ET), Military Malaria Research Program, Walter Reed Army Institute of Research (WRAIR).

Dr. Sciotti is recognized as a leader in malaria prophylaxis and small molecule antibiotic development for the DoD.

Dr. Sciotti’s primary goal is to deliver solutions that meet critical Warfighter needs. Dr. Sciotti developed a robust pipeline of new antimalarial drugs to address malaria’s threat as the primary infectious disease facing deployed Service Members. This was the first MRMC antimalarial drug candidate to advance to human clinical trials in more than 20 years.

Additionally, he has leveraged his extensive pharmaceutical industry experience to position WRAIR ET to deliver drug candidates for diseases of military importance other than malaria. Under Dr. Sciotti’s leadership, ET’s active collaborations have expanded to more than 60 academic, industry, government, and non-profit organizations. Dr.Sciotti is a model leader at WRAIR and continues to provide solutions to meet the critical concerns of the DoD.

by Toni Haynes